Additionally, while NPM, FLT3-ITD and DNMT3A mutations rarely co-occur in AML, they interact to drive the increased expression of the transcription factor hepatic leukemia factor (HLF) [49]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.